#Interferon-free

With interferon quickly becoming a thing of the past, what kind of side effects still remain in the new hepatitis C regimens?

Those with early cirrhosis, hoping to stall further deterioration don’t have the luxury of time.

“This is a very significant advance.”

BMS has submitted for approval in Japan daclatasvir and asunaprevir as the world’s first interferon- and ribavirin-free hep C treatment.

Gilead Sciences has planned a $47 million expansion of its Canadian pharmaceutical plant after its hepatitis C drug sofosbuvir moved closer to...

New hep C drugs are likely hitting the market in the very near future. But how long until interferon can be sent packing?

Faldaprevir and deleobuvir, plus ribavirin, cured genotype 1 of hepatitis C virus (HCV) in 52 to 69 percent of study participants in a recent...

Preparing for a great revolution in hepatitis C care, major pharmaceutical companies are in a mad dash toward achieving blockbuster status.

A cheap, generic anti-viral. It turns out that even with all the advances drug makers are realizing in interferon-free drug combinations, riba...

Promising Phase III results from a trial of Gilead Sciences’s hepatitis C antiviral sofosbuvir open the door for regulatory filing this...

The hepatitis C pipeline: huge changes on the horizon

Antiviral therapies faldaprevir and BI 207127 are safe and effective among people with hepatitis C virus, including those with advanced liver...

A combination of daclatasvir and sofosbuvir produced cures in more than 93 percent of hepatitis C patients, with or without the addition of ri...

Danoprevir and mericitabine, two experimental hepatitis C therapies, proved safe and effective among patients with previous treatment experien...

Abbott Laboratories’ three-drug regimen cured 97 percent of treatment-naive hepatitis C patients and 93 percent of those who had failed a prev...

A 24-week, interferon-free regimen pairing two drugs from Bristol-Myers Squibb--60 milligrams (mg) of daclatasvir, a once-daily NS5a...